from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1289/-

LFCtreatmentdescriptionclass of inhibitor

0.418

Amikacinug/mL Amikacintranslation

0.378

Cap5-10ug/mL Capreomycintranslation

-0.040

Rox10-50 ug/mL Roxithromycintranslation

0.514

SM2-5 ug/mL Streptomycintranslation

-2.257

Tet5-10 ug/mL Tetracyclinetranslation

0.450

Rif0.2-5ug/mL Rifampicintranscription

0.004

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.867

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.082

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.039

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.956

Clofazimine10-13 ug/mL Clofaziminerespiration

0.410

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.202

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.111

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.699

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.372

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.871

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.528

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.630

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.312

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.382

KCN5-20 ug/mL Potassium cyaniderespiration

1.892

NaN30.2-2 mM Sodium aziderespiration

-0.466

Nigericin50 uM Nigericinrespiration

0.041

TRC10-150 ug/mL Triclosanrespiration

-0.726

TRZ10-25 ug/mL Thioridazinerespiration

-0.948

Valinomycin0.5-10 uM Valinomycinrespiration

0.346

ZnSO42 mM ZnSO4respiration

-0.176

menadione6-10 ug/mL Menadionerespiration

-0.809

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.121

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.205

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.462

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.255

NRP_1Non-replicating persistence stage 1dosRassociated

-0.440

Amp0.2mg/mL AmpicillincellWall

0.027

Cephalexin20-100 ug/mL CephalexincellWall

-0.090

Cerulenin0.32-5 ug/mL CerulenincellWall

0.194

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.207

EMB10-20 ug/mL EthambutolcellWall

-0.262

Eta12-40 ug/mL EthionamidecellWall

-0.092

INH0.2-0.4 ug/mL IsoniazidcellWall

0.186

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.437

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.286

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.472

BZA0.12 mg/mL BenzamidearomaticAmides

-0.184

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.121

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.195

H2O24 mM hydrogen peroxideDNAdamaging

0.177

Levo10 ug/mL LevofloxacinDNAdamaging

-0.038

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.418

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.933

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.229

UVUV-irradiationDNAdamaging

-0.972

ARP41-4 ug/mL Antitubercular compound ARP4?

0.165

Antimycin12.5-50 ug/mL Antimycin A?

-0.422

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

1.477

PA_110-50 ug/mL Antitubercular compound PA-1?

0.953

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.140

PA8240.2-2 ug/mL PA-824?

1.497

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.450

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.263

Verapamil50 uM Verapamil?

-0.616

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.726

methoxatin10-20 ug/mL Methoxatin?